HMRI partners with Novartis (Aust & NZ) to supercharge heart health impact

The collaboration aims to eliminate barriers to screening and access for medically underserved women, leveraging data science and community-based research to develop targeted solutions. By listening to residents' experiences and challenges, USC and Novartis will create lasting improvements in breast cancer care.

Researchers at University of Melbourne and Pfizer discover new insights into a dual-target drug that may supercharge cancer-fighting immune cells, potentially leading to improved outcomes for breast cancer patients. The study found that this approach can enhance anti-tumor immunity by intratumoral CD8+ T cells.

Australian researchers have developed tiny compartments to help supercharge photosynthesis, enabling plants to fix carbon more efficiently. The team engineered encapsulins that can house the enzyme Rubisco in a confined space, allowing for fine-tuning of compatibility for future use in crops.

Researchers at the University of Bristol have discovered a method to supercharge soft robots and wearable technology by harnessing the surface tension of a tiny liquid metal droplet. This breakthrough enables the creation of more powerful devices with reduced complexity, benefiting rehabilitation patients and biomedical technologies.

The American Heart Association's Lp(a) Community Health Centers Discovery Project aims to increase awareness and shared decision making around Lp(a), a genetic risk factor for cardiovascular disease. By expanding access to Lp(a) screening, the initiative may help reduce the risk of ASCVD-related events such as heart attacks and strokes.

Elevated lipoprotein(a) is an independent genetic risk factor for cardiovascular disease. Community health centers participating in the Lp(a) Discovery Project and Community Health Centers Discovery Project have successfully added new screening processes, increasing testing at sites.